Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004086246 | SCV003548273 | uncertain significance | not specified | 2021-10-12 | criteria provided, single submitter | clinical testing | The c.2098G>A (p.E700K) alteration is located in exon 16 (coding exon 16) of the SORCS2 gene. This alteration results from a G to A substitution at nucleotide position 2098, causing the glutamic acid (E) at amino acid position 700 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003435894 | SCV004147665 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | SORCS2: BP4 |